These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 28834075)

  • 61. ISPAD Clinical Practice Consensus Guidelines 2014. Insulin treatment in children and adolescents with diabetes.
    Danne T; Bangstad HJ; Deeb L; Jarosz-Chobot P; Mungaie L; Saboo B; Urakami T; Battelino T; Hanas R;
    Pediatr Diabetes; 2014 Sep; 15 Suppl 20():115-34. PubMed ID: 25182312
    [No Abstract]   [Full Text] [Related]  

  • 62. Comparison of Different Models of Structured Self-Monitoring of Blood Glucose in Type 2 Diabetes.
    Li CL; Wu YC; Kornelius E; Chen YJ; Lin YT; Hsiao HW; Peng CH; Yang YS; Huang CN
    Diabetes Technol Ther; 2016 Mar; 18(3):171-7. PubMed ID: 26950418
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Individualised targets for insulin initiation in type 2 diabetes mellitus-the influence of physician and practice: a cross-sectional study in eight European countries.
    Boels AM; Koning E; Vos RC; Khunti K; Rutten GE
    BMJ Open; 2019 Aug; 9(8):e032040. PubMed ID: 31455718
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A cluster randomized trial on the effect of a multifaceted intervention improved the technical quality of diabetes care by primary care physicians: The Japan Diabetes Outcome Intervention Trial-2 (J-DOIT2).
    Hayashino Y; Suzuki H; Yamazaki K; Goto A; Izumi K; Noda M
    Diabet Med; 2016 May; 33(5):599-608. PubMed ID: 26331280
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Optimizing the management of hypoglycaemia in individuals with type 2 diabetes: A randomized crossover comparison of a weight-based protocol compared with two fixed-dose glucose regimens.
    Krebs JD; Weatherall M; Corley B; Wiltshire E; McTavish L
    Diabetes Obes Metab; 2018 May; 20(5):1256-1261. PubMed ID: 29359848
    [TBL] [Abstract][Full Text] [Related]  

  • 66. HbA1c response after insulin initiation in patients with type 2 diabetes mellitus in real life practice: Identifying distinct subgroups.
    Sidorenkov G; van Boven JFM; Hoekstra T; Nijpels G; Hoogenberg K; Denig P
    Diabetes Obes Metab; 2018 Aug; 20(8):1957-1964. PubMed ID: 29687577
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures.
    Lingvay I; Chao J; Dalal MR; Meneghini LF
    Diabetes Technol Ther; 2017 May; 19(5):315-322. PubMed ID: 28467113
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of once-weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c.
    Gallwitz B; Dagogo-Jack S; Thieu V; Garcia-Perez LE; Pavo I; Yu M; Robertson KE; Zhang N; Giorgino F
    Diabetes Obes Metab; 2018 Feb; 20(2):409-418. PubMed ID: 28817231
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of ranolazine on glycaemic control in patients with type 2 diabetes treated with either glimepiride or metformin.
    Pettus J; McNabb B; Eckel RH; Skyler JS; Dhalla A; Guan S; Jochelson P; Belardinelli L; Henry RH
    Diabetes Obes Metab; 2016 May; 18(5):463-74. PubMed ID: 26749407
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Subgroup analysis of phase 3 studies of dulaglutide in Japanese patients with type 2 diabetes.
    Onishi Y; Oura T; Nishiyama H; Ohyama S; Takeuchi M; Iwamoto N
    Endocr J; 2016; 63(3):263-73. PubMed ID: 26698689
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy.
    Shimoda S; Okubo M; Koga K; Sekigami T; Kawashima J; Kukidome D; Igata M; Ishii N; Shimakawa A; Matsumura T; Motoshima H; Furukawa N; Nishida K; Araki E
    Endocr J; 2015; 62(2):209-16. PubMed ID: 25392020
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Concordance the hemoglobin glycation index with glycation gap using glycated albumin in patients with type 2 diabetes.
    Kim MK; Jeong JS; Kwon HS; Baek KH; Song KH
    J Diabetes Complications; 2017 Jul; 31(7):1127-1131. PubMed ID: 28487124
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Clar C; Marien M; Richter B; Philip S
    Health Technol Assess; 2010 Jul; 14(36):1-248. PubMed ID: 20646668
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effectiveness of lifestyle-based weight loss interventions for adults with type 2 diabetes: a systematic review and meta-analysis.
    Terranova CO; Brakenridge CL; Lawler SP; Eakin EG; Reeves MM
    Diabetes Obes Metab; 2015 Apr; 17(4):371-8. PubMed ID: 25523815
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prevalence and predictors of clinical inertia in patients with type 2 diabetes who were treated with a single oral antidiabetic drug.
    Suzuki R; Kazumori K; Usui T; Shinohara M
    J Diabetes Investig; 2023 Jan; 14(1):81-91. PubMed ID: 36229998
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-term safety and efficacy of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes.
    Kadowaki T; Inagaki N; Kondo K; Nishimura K; Kaneko G; Maruyama N; Nakanishi N; Watanabe Y; Gouda M; Iijima H
    Diabetes Obes Metab; 2018 Jan; 20(1):77-84. PubMed ID: 28608617
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Patterns of diabetes care in Slovenia, Croatia, Serbia, Bulgaria and Romania : An observational, non-interventional, cross-sectional study.
    Cokolic M; Lalic NM; Micic D; Mirosevic G; Klobucar Majanovic S; Lefterov IN; Graur M
    Wien Klin Wochenschr; 2017 Mar; 129(5-6):192-200. PubMed ID: 27933508
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Effect of Dietary Glycaemic Index on Glycaemia in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Ojo O; Ojo OO; Adebowale F; Wang XH
    Nutrients; 2018 Mar; 10(3):. PubMed ID: 29562676
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hypoglycaemia: costs, insulins and prevention.
    Holt RI
    Diabet Med; 2016 Apr; 33(4):419-20. PubMed ID: 26995756
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.